Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report
Lists
Only you see this
Abstract
This preliminary study informs that HIV-1 INRs, allogenic NK cells immunotherapy is safe and could significantly improve CD4 recovery but not CD4/CD8 ratio. The practical effects, however, need long-term follow-up observations. Further study on the potential underlying mechanism is warranted. REGISTRATION INFO:: www.chictr.org.cn/showproj.aspx?proj=34912 (No. ChiCTR1900020634).
BibTeX
@inproceedings{xia2020safety,
author = {Huan Xia and Yin Wang and Huali Sun and Liying Gao and Yu Cao and Silvère D. Zaongo and Rong-Nan Zeng and Hao Wu and Mingjie Zhang and Ping Ma},
title = {{Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report}},
booktitle = {Chinese},
year = {2020},
doi = {10.1097/cm9.0000000000001189},
}Loading related content...